Back to Companies
ENANTA PHARMACEUTICALS INC
ENTANasdaqCIK: 0001177648
ENANTA PHARMACEUTICALS INC (ENTA) shows 30 recent insider filings from 11 insiders, with all of them on the sell side. With $0 in purchases and $183.2K in sales, the recent tape is heavily weighted toward selling (net sales of $183.2K). Luly Jay R. (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $4.2M by Luly Jay R.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$12.6M
Purchases
$0
Sales
$183.2K
Unique Insiders
11
Recent Insider Trades
30 loaded
| Aug 10 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Tax withheld | $19.6K |
| Mar 13 | ENTA ENANTA PHARMACEUTICALS INC | FOLETTA MARK G | Director | Award | $283.4K |
| Mar 13 | ENTA ENANTA PHARMACEUTICALS INC | Vance Terry | Director | Award | $283.4K |
| Mar 13 | ENTA ENANTA PHARMACEUTICALS INC | Hata Yujiro S | Director | Award | $283.4K |
| Feb 13 | ENTA ENANTA PHARMACEUTICALS INC | Kowalsky Matthew Paul | Chief Legal Officer | Grant | $27.1K |
| Feb 13 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Grant | $48.6K |
| Feb 13 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant | $46.4K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Or Yat Sun | Chief Scientific Officer | Sell | $34.0K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Luly Jay R. | President and CEO, Director | Sell | $67.5K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Sell | $11.4K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | See Remarks | Sell | $7.7K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Sell | $4.6K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | $30.0K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Luu Brendan | Chief Business Officer | Sell | $19.8K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Sell | $2.9K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Luly Jay R. | President and CEO, Director | Tax withheld | $26.6K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Luu Brendan | Chief Business Officer | Tax withheld | $7.0K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | See Remarks | Sell | $5.3K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax withheld | $10.6K |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | See Remarks | Grant | $176.6K |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Luu Brendan | Chief Business Officer | Award | $1.2M |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Or Yat Sun | Chief Scientific Officer | Award | $1.5M |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Kowalsky Matthew Paul | Chief Legal Officer | Award | $1.2M |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Award | $1.4M |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Award | $1.5M |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Grant | $86.4K |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Luly Jay R. | President and CEO, Director | Award | $4.2M |
| Sep 8 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | Vice President, Finance | Other | $0 |
| Sep 8 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Other | $0 |
| Aug 8 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Tax withheld | $15.5K |
30 filings